Comparative inotropic effect of calcium, endothelin-1, and forskolin on ferret papillary muscles during acidosis.
Acidosis affects multiple steps in the excitation-contraction coupling pathway of myocardium, producing decreased calcium sensitivity of myofibrils and modification of the function of the sarcoplasmic reticulum. Our aim was to evaluate the effectiveness of three different classes of inotropic agents under acidotic conditions: 1) forskolin, an adenylate cyclase activator that enhances cellular cyclic AMP concentrations, 2) elevated extracellular Ca2+ and 3) endothelin-1, an activator of the inositol triphosphate, diacylglycerol pathway. Ferret papillary muscles were mounted in organ baths containing normal physiological solution (pH = 7.4). After baseline tension was measured, the muscles were bathed in an acidotic solution (pH = 6.98) that decreased tension to 40% of the control; subsequently, the muscles were washed with normal physiological solution until they returned to baseline. Each inotropic agent was added to the bathing solution in a concentration sufficient to increase tension by 40% above the baseline. Then the solution was made acidotic (pH = 6.98) in the continuous presence of that concentration of inotropic agent and the resultant steady-state developed tension measured. The increases in tension induced by each inotropic agent at normal pH were adjusted to be similar: in contrast, the response to each drug in acidosis was significantly different. Under acidotic conditions, endothelin-1 was the most effective inotropic agent in restoring the depressed developed tension. This was possibly due to enhancement of the myofilament sensitivity to Ca2+, which was more effective than increasing [Ca2+]i through elevating extracellular Ca2+ or the addition of forskolin which increased [Ca2+]i but desensitized the myofilaments to Ca2+.
Ishiguro
Y
Y
Charles A Dana Research Institute, Beth Israel Hospital, Boston, MA, USA.
Morgan
J P
JP
D000138:Acidosis / Q000378:metabolism / Q000503:physiopathology*; D000249:Adenosine Monophosphate / Q000378:metabolism; D000818:Animals; D002118:Calcium / Q000378:metabolism / Q000494:pharmacology*; D005576:Colforsin / Q000494:pharmacology*; D004594:Electrophysiology; D019332:Endothelin-1 / Q000494:pharmacology*; D005289:Ferrets; D006863:Hydrogen-Ion Concentration; D066298:In Vitro Techniques; D008297:Male; D009200:Myocardial Contraction / Q000187:drug effects*; D010210:Papillary Muscles / Q000187:drug effects*; D013268:Stimulation, Chemical
D019332:Endothelin-1; D005576:Colforsin; D000249:Adenosine Monophosphate; D002118:Calcium